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Abstract
Background: Abnormalities in cognition have been reported in patients with Bipolar Disorder (BD) and their first degree
relatives, suggesting that susceptibility genes for BD may impact on cognitive processes. Recent genome-wide genetic
studies have reported a strong association with BD in a single nucleotide polymorphism (SNP) (rs10994336) within ANK3,
which codes for Ankyrin 3. This protein is involved in facilitating the propagation of action potentials by regulating the
assembly of sodium gated ion channels. Since ANK3 influences the efficiency of transmission of neuronal impulses, allelic
variation in this gene may have widespread cognitive effects. Preclinical data suggest that this may principally apply to
sequential signal detection, a core process of sustained attention.
Methodology/Principal Findings: One hundred and eighty-nine individuals of white British descent were genotyped for the
ANK3 rs10994336 polymorphism and received diagnostic interviews and comprehensive neurocognitive assessment of their
general intellectual ability, memory, decision making, response inhibition and sustained attention. Participants comprised
euthymic BD patients (n=47), their unaffected first-degree relatives (n=75) and healthy controls (n=67). The risk allele T
was associated with reduced sensitivity in target detection (p=0.0004) and increased errors of commission (p=0.0018)
during sustained attention regardless of diagnosis. We found no effect of the ANK3 genotype on general intellectual ability,
memory, decision making and response inhibition.
Conclusions/Significance: Our results suggest that allelic variation in ANK3 impacts cognitive processes associated with
signal detection and this mechanism may relate to risk for BD. However, our results require independent replication and
confirmation that ANK3 (rs10994336) is a direct functional variant.
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Introduction
Bipolar Disorder (BD) is a complex, highly heritable disease [1].
A genome-wide association study [2], which combined data from
two previously published samples [3] and [4], reported a strong
association (p=9.1610
29) between BD and a region (rs10994336)
in ANK3 on chromosome 10q21. Within the nervous system, the
protein coded by ANK3, known as Ankyrin3 or AnkyrinG, is
localised in the initial axonal segment and the nodes of Ranvier
[5]. It is involved in the normal clustering of sodium gated
channels thus enabling the propagation of action potentials in
myelinated neurons [6].
The focus on the potential relevance of ion channels for
psychiatric disorders is relatively new; to date channelopathies
were mostly considered in the context of cardiac [7] and motor [8]
syndromes and of seizure or migraine disorders [9]. However
there is empirical support for the significance of ion channels for
the clinical symptoms of BD; both Lithium [10,11] and
antiepileptics that have long been successfully used for the
treatment of BD are now known to modulate ion channels [12].
In parallel to developments in genetic studies, the cognitive
function of BD patients and their relatives has received much
attention, particularly as cognition is considered more directly
linked to genetic liability [13]. Evidence from multiple studies
[14,15,16] support the role of several cognitive processes as
potential endophenotypes for BD. Therefore examination of the
effect of recently identified risk genes on cognition may prove
fruitful in delineating cognitive processes, and by inference neural
systems, that may mediate genetic risk.
At present, our understanding of the functional significance of
the allelic variation of ANK3 for complex behaviour, either in
health or in disease, is rudimentary. However, it has long been
known that retinal ganglion cells are dependent on sodium
channels for action potential generation [17]; furthermore, these
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ratio thus enhancing visual information processing [18]. Preclin-
ical and computational models suggest that stimulus encoding
within neuronal populations is dependent on the speed of action
potential onset [19]. This is determined by the clustering and
cooperative activation of voltage-gated sodium channels [20], for
which Ankyrin3 is required [6]. Finally, attentional processes are
associated with functional coupling of prefrontal and visual
cortices within the gamma frequency band [21] which is also
dependent on optimal sodium channel function [22]. Therefore
investigating the potential effect of ANK3 on visual sustained
attention represents a logical first step in unravelling genotype-
phenotype relationships.
To this aim we evaluated cognitive function in patients with BD,
their first degree relatives and healthy controls genotyped for
ANK3 and undertook two analyses. A hypothesis led analysis on
the effect of the ANK3 genotype and its interaction with diagnosis
on target detection as assessed with the Degraded Symbol
Continuous Performance task (DS-CPT) [23,24]. As understand-
ing of the functional impact of ANK3 on cognition is currently
limited we also undertook a hypothesis generating analyses on the
effect of allelic variation in ANK3 on other aspects of cognition.
Methods
We genotyped participants of the Vulnerability to Bipolar
Disorder Study (n=189) [25]. Cognitive and clinical information
on this sample was already available. Patients were identified by
clinicians’ referrals and were included if they (a) were aged
between 17–65 years (b) fulfilled Diagnostic and Statistical Manual
of Mental Disorders, 4th edition, revised (DSM-IV) [26] criteria
for Bipolar Disorder, type I (BD-I), (c) had at least one first degree
relative unaffected by BD and (d) no family history (up to second
degree) of schizophrenia or schizophrenia spectrum disorders.
Their siblings and offspring were invited to participate, with the
patients’ consent, if aged 17–65 and without a personal history of
Bipolar Spectrum Disorders.
Healthy volunteers were recruited through advertisement in the
local press and were enrolled if they were (a) aged 17–65 years and
(b) had no personal or family history of any Axis I or II DSM-IV
disorder. Healthy volunteers were selected so that they matched
both patients and relatives in gender and level of education. Level
of education was rated on a 5-point scale ranging from 1 (no
educational qualification) to 5 (post graduate university level
qualifications).
Exclusion criteria for the entire sample (patients, relatives and
controls) included (a) head trauma resulting in loss of conscious-
ness, (b) personal history of neurological or medical disorders, (c)
family history of hereditary neurological disorders and (d) fulfilling
DSM-IV criteria for lifetime drug or alcohol dependence and drug
or alcohol abuse in the preceding six months.
Ethics Statement
The study was approved by the Ethics Committee of the
Institute of Psychiatry. Written informed consent was obtained
from all participants and all clinical investigations were conducted
according to the principles expressed in the Declaration of
Helsinki.
Clinical Assessment
All participants were interviewed personally by trained
psychiatrists, who were initially blind to diagnostic but not family
status (BD family member or unrelated control), using the
Structured Clinical Interview for DSM-IV (SCID) for Axis I
(patient and non-patient version) [27,28]. Inter-rater reliability was
kappa.0.92 for both instruments. Where applicable, further
information about age of onset, number and polarity of previous
episodes, number of hospital admissions and current medication
(type, dose and duration) was collected from medical notes. Family
history of psychiatric disorders was assessed using the Family
Interview for Genetic Studies (FIGS) [29] supplemented by
medical notes as necessary. Participants were rated using the
Hamilton Depression Rating Scale (HDRS) [30], the Young
Mania Rating Scale (YMRS) [31], and the Brief Psychiatric
Rating Scale (BPRS) [32]. Prior to cognitive assessment all
participants with an Axis I disorder were assessed weekly over a
period of one month to ensure that at each assessment they (a)
scored below 7 in the HDRS and YMRS and (b) there had been
no change to their type and dose of medication.
Cognitive Assessment
All participants were assessed using the same battery adminis-
tered in a single session by qualified psychologists. An estimate of
current full-scale intelligence quotient (FSIQ) was obtained using
the Wechsler Adult Intelligence Scale-Revised (WAIS-R) [33].
Sustained attention was measured using the Degraded Symbol
Continuous Performance task (DS-CPT) [23,24]. This task
provides a sensitive measure of subtle deficits in signal detection
over sustained periods of visual monitoring with minimal working
memory involvement. Participants were shown images of numerals
degraded to a fixed degree by blurring and superimposing a
random pattern of visual noise. The stimuli were presented for
28 ms each at a rate of 1 per second on a computer screen situated
1 meter away from the participants. They were instructed to
respond as quickly as possible by button press when a pre-
designated target numeral ‘‘0’’ appeared. The target numeral
occurred in a quasi-random fashion in 25% of the 480 trials. The
numerals immediately preceding the target were balanced to
eliminate sequence recognition. Although stimuli are presented
continuously the data was analysed in blocks of trials. The first 160
trials are practice trials and were excluded from the analysis, while
the remainder were divided in 4 blocks of 80 trials each. For each
block the following four dependent variables were used: 1) hit rate
or number of correct responses, 2) false alarm rate or number of
errors of commission 3) response criterion, which reflects the
amount of perceptual evidence required prior to responding to a
stimulus as a target, and 4) d9, a non-parametric signal detection
index of sensitivity, a measure of target detection.
The effect of allelic variation in ANK3 on any aspect of cognition
is not known; given the role of ANK3 in fundamental aspects of
neuronal firing and neural connectivity we explored the possibility
that its impact on cognition might be quite broad. Therefore we
examined the effect of the genotype on all cognitive tests for which
complete information was available for all participants. These
were the Stroop Colour Word Test (SCWT) [34], the Wisconsin
Card Sorting Test (WCST) [35], a test of rule discovery and
perseveration, the Wechsler Memory Scale- 3rd Edition UK
(WMS-III) [36], and the Iowa Gambling Task (IGT) [37] which is
widely used to assess decision-making. We used the paper and
pencil version of the SCWT in which participants are asked to
read colour words (non-interference condition) or to name the font
colour of incongruous colour words (interference condition). The
outcome variable included in the analysis was total correct
responses in the incongruent condition. In the WCST, participants
were required to sort a deck of cards on the basis of a series of
unknown categories. Feedback was given after each match to
enable identification of the correct matching rule. After a number
of correct responses, the card-sorting category changed. The
ANK3 and Sustained Attention
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measure of rule discovery) and number of perseverative errors.
The WMS-III focuses on immediate, delayed and working
memory, tested in two modalities, auditory and visual and in
two task formats, recall and recognition. Six outcome variables
from the test were considered auditory and visual immediate
memory, immediate memory, auditory and visual delayed
memory and auditory recognition delayed memory. Finally, in
the IGT, participants were instructed to maximise simulated
monetary gains by selecting a total of 100 cards (one at a time)
from four decks (A,B,C, D) displayed on a computer screen. The
reward or penalty associated with their choice was displayed on
the screen after card selection. Decks A and B were ‘‘disadvan-
tageous’’ as they were associated with large rewards but higher
penalties; in contrast, Decks C and D were ‘‘advantageous’’
despite lower gains per card as their penalties were also lower.
Participants were not told the distribution of wins and losses
associated with the decks; rewards and punishments were
sequenced so that it was difficult to work this out. It is expected
that over time participants will learn to favour the advantageous
cards. Emotional learning is a measure of this derived by
subtracting the quotient C+D/A+B of the last 20 trials from that
of the first 20 trials.
Genotyping
DNA was obtained from buccal swabs using established
procedures [38]. The ANK3 T/C (rs10994336) genotype was
determined by a ‘TaqMan’ allelic discrimination assay (Applied
Biosystems, Assay ID C_31344821_10). End point analysis was
performed using the Applied Biosystems 7900HT Fast Real-Time
PCR System and genotypes were called with the SDS 2.3 software.
Statistical analysis
To compare demographic features, we conducted univariate
analyses of variance (ANOVAs) for continuous variables with
genotype and affection status (BD patient, relative, control) as fixed
factors and chi-square tests for dichotomous variables. We used
the same approach when comparing the effect of genotype on the
clinical characteristics of BD patients.
We examined the normality of distribution of the neurocogni-
tive variables in the entire sample with goodness of fit
Kolmogorov-Smirnov tests. For normally distributed variables
we used univariate, multivariate or repeated measures analysis of
covariance with total BPRS score as covariate to examine the
main effects and interaction of genotype and affection status.
Although YMRS and HAMD data on the entire sample were
available these scales are not standardised for use in non-clinical
populations. Therefore, the 24-item BPRS was chosen to allow
meaningful comparisons between patient and non-patient groups
as it can be used to rate both non-pathological (item ratings below
3) and pathological experiences (item ratings of 4–7).
For non-normally distributed variables we employed a simula-
tion method, whereby we retained the phenotypic data (cognitive
variables and affection status) and permuted the observed
genotype among individuals using the R statistical package
(http://cran.r-project.org). We analyzed the data using the
ANOVA and retained the test statistic (F-values). The random
assignment of genotypes was repeated 100,000 times to derive a
distribution of F-values. The latter analysis was conducted twice;
once including only completely asymptomatic participants (BPRS
score,27) and once including the entire sample while co-varying
for BPRS score. Comparison of the observed F-values with the
distribution from the simulation method produced empirical p-
values which are robust to the non-normal distribution of the
phenotype.
As this is the first study to report on the effect of ANK3 T/C on
neurocognitive task performance ap r i o r ipower calculations were not
possible. We therefore calculated Cohen’s d9 effect sizes [39] and
conducted post-hoc power calculations for the main effect of genotype
on all neurocognitive variables using Quanto software (hydra.usc.edu/
GxE) assuming a minimum allele frequency 0.067 (hapmap.ncbi.
nlm.nih.gov/cgi-perl/snp_details_B36?name=rs10994336&source=
hapmap24_B36) and an additive model.
Results
Sample Characteristics
Ninety-two BD patients from an equal number of families were
screened by telephone interview for eligibility by a trained
psychiatrist. Families of 53 BD patients were enrolled in the
study; these yielded 47 BD-I patients (6 patients were further
excluded as they did not meet remission criteria throughout the
study period) and 75 first-degree relatives. All participants were of
self-reported British white ancestry. For the current analysis, 1 BD
patient and 2 relatives were excluded due to failure in genotyping.
Detailed flow chart of study sample recruitment is shown in
Figure 1 while demographic and clinical details are shown in
Table 1. BD patients had significantly higher HAMD, YMRS and
BPRS scores than relatives and controls (all p,0.001) while the
two latter groups did not differ from each other. The scores of the
three rating scales were highly correlated (r=0.73, p=0.0001).
Genotype Distribution
Due to the rarity of the T allele (CEU MAF 0.07; www.
hapmap.org), only one TT homozygote was identified and was
analysed together with the heterozygotes. Genotype frequencies in
unrelated participants were in Hardy-Weinberg equilibrium
(p=0.65). In total, 165 individuals (39 BD patients, 58 relatives
and 68 controls) were C homozygotes and 21 (7 BD patients, 5
relatives and 9 controls) carried the risk allele T. There were no
affection status by genotype interactions for age at assessment
(F2, 185=0.51, p=0.60), gender or educational status (all p.0.43).
Genotype Effect on clinical variables
In the BD patient group, there was no genotype effect on age of
onset (F1, 45=0.90, p=0.35) or duration of illness (F1, 45=0.16,
p=0.70) or on the rates of psychosis (x
2=0.42, df=1, p=0.53).
Although the carriers of the risk allele (T) had more depressive
(F1, 45=7.65, p=0.009,) and manic episodes (F1, 45=8.53,
p=0.006).
The relationship of genotype, affection status and
cognition
Details of the neurocognitive outcome variables by affection
status and genotype are shown in Table S1 (supplemental
material).
Sustained Attention
None of the outcome variables of the DS-CPT were normally
distributed. Logarithmic transformation failed to normalise the
distribution. Initial exploration of the impact of genotype and
affection status on DS-CPT outcome variables was conducted
using repeated measures analysis of variance with blocks 1–4 as
within subject factor and affection status and genotype as between-
subject factors and BPRS as covariate. Where the sphericity
assumption was violated, we report results using the Greenhouse-
ANK3 and Sustained Attention
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affection status or block by genotype or block by affection status
and by genotype for Hit Rate (all p.0.26), Response criterion (all
p.0.12) and reaction time (all p.0.17). The effect size of the
genotype was negligible for Hit Rate (Cohen’s d=0.08) and small
for Response Criterion and reaction time (Cohen’s d,0.25) so it is
unlikely that these results reflect lack of power.
The within subjects main and interaction effects for False Alarm
(F6, 177=0.82, p=0.55) and Sensitivity (F4.25, 376.66=0.94,
p=0.47) were not significant. In contrast, the interaction between
block and genotype was significant both for False Alarms
(F3, 177=2.64, p=0.05) and Sensitivity (F2.12, 376.66=2.57,
p=0.05). However polynomial linear within-subject contrasts
revealed substantial 2 way interaction of genotype by block for
False Alarms and Sensitivity (p=0.014 and 0.038 respectively). In
addition, the between subject effects of genotype was significant for
both False Alarm (F1,177=9.02, p=0.003) and Sensitivity
(F1,177=10.45, p=0.001).
Since parametric analysis of non-parametric data may inflate
the likelihood of false positive results we employed a simulation
method focusing on the last block where the effect size of the
genotype was the largest with Cohen d9 being 0.83 and 0.92 for
False Alarms and Sensitivity respectively. The effect of genotype
remained significant both for False Alarms and Sensitivity; when
excluding participants with a BPRS.27 we obtain empirical p-
values of 0.0018 and 0.0004 for False Alarms and Sensitivity and
the respective p-values when using BPRS as a covariate were
0.0021 and 0.0008. These p-values also withstand Bonferroni
correction for multiple comparisons. In all analyses, the risk allele
(T) was associated with poorer performance.
Exploratory analyses of other cognitive variables
There was no significant main effect of genotype or genotype by
affection status interaction on test performance on the WAIS-R,
SCWT, WCST, and WMS-III and IGT (all p.0.26) (Table 2).
The effect of allelic variation in ANK3 was negligible for FSIQ
(Cohen’s d=0.14), WCST categories achieved and perseverative
errors (Cohen’s d=0.05 for both) and IGT (Cohen’s d=0.02). For
all WMS-III variables the effect of ANK3 ranged from negligible to
small (Cohen’s d range 0.03–0.17) with the exception of the
composite index of working memory where a moderate effect size
(Cohen’s d=0.35) was noted. Similarly a medium effect size of
Figure 1. VIBES Sample Identification and recruitment.
doi:10.1371/journal.pone.0016671.g001
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with poorer performance on all of these measures.
Discussion
This is first study to examine the effect of allelic variation in
ANK3 on cognition in BD patients, their relatives and healthy
controls. We found that the ANK3 genotype may be specifically
associated with visual sustained attention but not with measures
of global intellectual function such as IQ. The effect of the
ANK3 genotype was also exploredi nt h ed o m a i n so fm e m o r y ,
response inhibition, decision making and executive function.
With the exception of response inhibition the effect sizes
observed in all other cognitive domains ranged from negligible
Table 1. Demographic and Clinical details of the sample.
ANK3 BD Patients N=46 Relatives N=73 Controls N=67
Age (years) CC 43.88 (10.68) 32.94 (11.64) 36.20 (13.17)
CT and TT 45.43 (11.54) 32.80 (15.34) 37.56 (14.65)
Age range(years) CC 21–58 17–58 18–59
CT and TT 25–56 18–58 20–58
Educational Level CC 3.60 (0.99) 3.75 (0.87) 3.59 (0.98)
CT and TT 3.20 (0.82) 3.20 (0.84) 3.64 (1.12)
BPRS total score CC 27.78 (3.77) 24.74 (1.71) 24.24 (0.50)
CT and TT 24.57 (0.98) 24.40 (0.89) 24.82 (0.98)
Age of onset (years) CC 26.40 (8.86) ___ -----
CT and TT 23.29 (7.74) ___ ----
Duration of illness (years) CC 20.29 (10.23) ___ ----
CT and TT 22.57 (8.98) ___ ----
Depressive episodes (n)* CC 3.83 (2.96) ___ ----
CT and TT 11.33 (14.11) ___ ----
Manic episodes (n)* CC 2.57 (2.54) ___ ----
CT and TT 12.20 (16.19) ___ ----
Continuous data shown as mean (sd); BPRS=Brief Psychiatric Rating Scale; HAMD=Hamilton Depression Rating Scale; YMRS=Young Mania Rating Scale; GAF=Global
Assessment of Functioning *p,0.006.
doi:10.1371/journal.pone.0016671.t001
Table 2. Power calculations for the effect of ANK3 on cognitive function.
Cognitive variable N % variance explained Number needed for 80% power
WAIS-R FULL IQ 183 0.16 4843
DS-CPT: hit rate 184 0.05 15630
DS-CPT: false alarms 184 7.9 95
DS-CPT: target sensitivity (d9) 184 11 67
DS-CPT: response criterion 184 0.55 1413
SCWT 168 1.67 465
WCST: categories achieved 186 0.007 118133
WCST: perseverative errors 186 0.1 7592
WMS-III: auditory immediate memory 184 0.0003 .10
6
WMS-III: visual immediate memory 184 0.18 4431
WMS-III immediate memory 184 0.11 7251
WMS-III auditory delayed 184 0.18 4293
WMS-III visual delayed 184 0.03 29335
WMS-III auditory recognition delayed 184 0.14 5787
WMS-III general memory 184 0.03 29921
WMS-III working memory 184 1.17 670
IGT: Emotional Learning 178 0.04 18162
WAIS-R=Wechsler Adult Intelligence Scale-Revised; DS-CPT=Degraded Symbol Continuous Performance Test; SCWT=Stroop Colour Word Test; WCST=Wisconsin Card
Sorting Test; WMS-III=Wechsler Memory Scale-3
rd edition; IGT=Iowa Gambling Task.
doi:10.1371/journal.pone.0016671.t002
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[39].
The version of the CPT employed here depends on the effortful,
sequential processing of multiple ambiguous visual targets but not
on working memory processes that rely on representations of
preceding stimuli [24,40]. Performance decrements in this task
may reflect shifts in sensitivity or response criterion or both. In this
study, the risk allele (T) was associated with worse performance in
the DS-CPT in terms of False Alarms and Sensitivity but not Hit
Rate or Response Criterion. This suggests a specific effect of the
ANK3 in decreasing signal detection rather than lowering response
criteria. The latter is often assumed to reflect increased
‘‘impulsivity’’ in responding [41] which does not appear to be
the case here; this finding resonates with previous results from
independent samples of BD patients suggesting that increased
impulsivity may not be a trait feature of BD [42]. The mechanism
underlying the association between ANK3 and reduced sensitivity
in target detection is beyond the resolution of our methodology.
However, the potential impact of ANK3 on sodium channel
clustering and action potential propagation may impact on
stimulus encoding and coupling of prefrontal and visual cortices
[18–22], both key processes relating to signal detection [43].
There are several important methodological considerations.
Firstly, there are several genes as well as behavioural, clinical and
cognitive phenotypes for BD that could have been examined in
this dataset. However, the simultaneous investigation of all possible
combinations corrected for multiple comparisons would require
very large datasets with the same or comparable measures on all
participants. Although ideal, this is currently not feasible. At the
same time, exploring the potential effect size of genetic
polymorphisms in smaller, well characterised datasets has the
potential of informing future collaborative approaches and
reducing the number of target phenotypes. Secondly, the study
sample comprised of individuals already in our database and was
not specifically obtained for examining the effect of rs10994336.
We fully appreciate that our sample size is moderate but we
believe that to a large extent this is, at present, inevitable, as
ANK3 is not a gene that was theoretically predicted as being of
relevance to BD. Thirdly, the risk conferring allele is exceedingly
rare and was therefore only identified in large samples pooled from
different studies. Such pooled samples do not have detailed
phenotypic information apart from diagnosis. Therefore we
consider this paper as a first step in the process of unravelling
the functional significance of the genes identified for BD. Fourthly,
given the moderate size of our sample we were rigorous in the
statistical approach employed to minimise the likelihood of
spurious findings. Additionally, we have provided estimates of
effect size for all our analyses that allows further inspection of the
statistical properties of the dataset. Fifthly, since there is no
information at present on whether the SNP in the ANK3 gene
(rs10994336) is a direct functional variant or a tagging SNP, which
may reflect the effect of another, as yet unknown, variant which
has a direct functional effect on both risk of BD and visual
sustained attention. Finally, decrements in sensitivity during the
DS-CPT have been observed in other disorders notably
schizophrenia where they seem to play a more important role
than in BD [44]. An association between ANK3 and schizophre-
nia (albeit with a different risk marker in the first intron of ANK3
on 10q21) has already been reported [45] underlying the
importance of this gene for psychotic disorders.
In summary, we report a relatively selective effect of the ANK3
polymorphism on sensitivity to signal detection affecting individ-
ual’s sustained attention and possibly contributing to the risk for
BD. Further investigations are required to confirm the functional
variant of ANK3 and to investigate the electrophysiological
implications of genetic variability in this locus.
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